Phase I Study of Safety and Immunogenicity of ADU-623

Clinical trial NCT01967758 · COMPLETED

Trial details

NCT number: NCT01967758
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Astrocytic Tumors Glioblastoma Multiforme Anaplastic Astrocytoma Brain Tumor

Start date: 2014-01-08
Primary completion: 2018-06-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.